Product Description
Overall, the global embolic protection device market was valued at $110 million in 2023. This is expected to increase over the forecast period at a CAGR of 0.6% to reach $115 million.
The full report suite on the global market for embolic protection devices (EPDs) includes a meticulous examination across seven prominent geographical regions, namely North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia Pacific and Africa. Within each of these delineated regions, a comprehensive scrutiny will be conducted encompassing various facets, including market valuation, unit analysis and ASP. Moreover, the report will extend its projections up to the year 2030, thereby providing a comprehensive and anticipatory understanding of the market trends and trajectories for the given period.
DATA TYPES INCLUDED
- Procedure Numbers, Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Embolic Protection Device Market Analysis
Global Embolic Protection Device Market Share Analysis
In 2015, Medtronic entered the U.S. EPD market by acquiring Covidien, gaining the SpiderFX™ device with approvals for carotid, lower limb, and saphenous vein grafting indications. As of 2023, Medtronic’s SpiderFX™ leads the standalone EPD market for lower-limb procedures.
Abbott Vascular, entering the EPD market in 2006, acquired Guidant’s platforms, becoming the first to offer a carotid-approved EPD. Abbott’s enduring market presence is marked by innovations like the sixth-gen Emboshield® NAV6 system in 2009 and the expanded RX Accunet® EPD indication in 2011.
Boston Scientific’s FilterWire EZ™ is designed for carotid and SVG indications, providing embolic protection across vessel sizes. The 2018 acquisition of Claret Medical added the Sentinel™ cerebral protection system, enhancing Boston Scientific’s TAVR product line with improved market synergy.
Market Segmentation Summary
- Carotid Embolic Protection Device Market
- Renal Embolic Protection Device Market
- Lower-Limb Embolic Protection Device Market
Global Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2023 |
| Forecast | 2024-2030 |
| Historical Data | 2020-2023 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
